Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.6500 (5.81%) ($5.2000 - $5.6800) on Wed. Feb. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 60 | Latest Price | $5.6500(5.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.7% a day on average for past five trading days. | Weekly Trend | EYES advances 3.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(19%) SHY(18%) VIXM(12%) BNDX(11%) VXX(10%) | Factors Impacting EYES price | EYES will decline at least -2.835% in a week (0% probabilities). QQQ(-18%) XOP(-17%) XLK(-17%) IYT(-17%) XRT(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | 0 () | Intraday Trend | 7% | | | |
|
5 Day Moving Average | $5.7(-0.88%) | 10 Day Moving Average | $5.58(1.25%) | 20 Day Moving Average | $5.21(8.45%) | To recent high | -22.5% | To recent low | 12.8% | Market Cap | $1.805b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |